Puma Biotechnology Stock Performance

PBYI Stock  USD 6.79  0.11  1.65%   
On a scale of 0 to 100, Puma Biotechnology holds a performance score of 17. The company holds a Beta of 0.53, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Puma Biotechnology's returns are expected to increase less than the market. However, during the bear market, the loss of holding Puma Biotechnology is expected to be smaller as well. Please check Puma Biotechnology's expected short fall, and the relationship between the maximum drawdown and rate of daily change , to make a quick decision on whether Puma Biotechnology's historical price patterns will revert.

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Puma Biotechnology are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. Despite fairly inconsistent basic indicators, Puma Biotechnology demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more

Actual Historical Performance (%)

One Day Return
1.65
Year To Date Return
17.68
Ten Year Return
(85.32)
All Time Return
(51.50)
1
3 Intriguing Penny Stocks With Market Caps At Least 50M
11/21/2025
2
CRMD vs. PBYI Which Small-Cap Biotech Stock Is the Better Buy
12/17/2025
3
Up 91 percent in the Past Year, Is This Biotech Stock Red Hot or a Red Flag
12/31/2025
4
Disposition of 4540 shares by Maximo Nougues of Puma Biotechnology at 5.844 subject to Rule 16b-3
01/06/2026
5
Disposition of 6405 shares by Maximo Nougues of Puma Biotechnology at 5.879 subject to Rule 16b-3
01/07/2026
6
Insider Selling Puma Biotechnology Insider Sells 3,973 Shares of Stock
01/09/2026
7
Puma Biotechnology Price Target Increased by 42.86 percent to 5.10 - Nasdaq
02/03/2026
8
Exelixis Q4 Earnings and Revenues Beat Estimates
02/10/2026
Begin Period Cash Flow86.7 M
Total Cashflows From Investing Activities-20.4 M

Puma Biotechnology Relative Risk vs. Return Landscape

If you would invest  498.00  in Puma Biotechnology on November 22, 2025 and sell it today you would earn a total of  181.00  from holding Puma Biotechnology or generate 36.35% return on investment over 90 days. Puma Biotechnology is currently generating 0.5565% in daily expected returns and assumes 2.4601% risk (volatility on return distribution) over the 90 days horizon. In different words, 22% of stocks are less volatile than Puma, and 89% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Puma Biotechnology is expected to generate 3.28 times more return on investment than the market. However, the company is 3.28 times more volatile than its market benchmark. It trades about 0.23 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.14 per unit of risk.

Puma Biotechnology Target Price Odds to finish over Current Price

The tendency of Puma Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 6.79 90 days 6.79 
about 11.39
Based on a normal probability distribution, the odds of Puma Biotechnology to move above the current price in 90 days from now is about 11.39 (This Puma Biotechnology probability density function shows the probability of Puma Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Puma Biotechnology has a beta of 0.53 indicating as returns on the market go up, Puma Biotechnology average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Puma Biotechnology will be expected to be much smaller as well. Additionally Puma Biotechnology has an alpha of 0.4704, implying that it can generate a 0.47 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Puma Biotechnology Price Density   
       Price  

Predictive Modules for Puma Biotechnology

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Puma Biotechnology. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Puma Biotechnology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
4.446.909.36
Details
Intrinsic
Valuation
LowRealHigh
3.796.258.71
Details
Naive
Forecast
LowNextHigh
4.146.609.06
Details
2 Analysts
Consensus
LowTargetHigh
4.555.005.55
Details

Puma Biotechnology Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Puma Biotechnology is not an exception. The market had few large corrections towards the Puma Biotechnology's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Puma Biotechnology, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Puma Biotechnology within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.47
β
Beta against Dow Jones0.53
σ
Overall volatility
0.68
Ir
Information ratio 0.18

Puma Biotechnology Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Puma Biotechnology for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Puma Biotechnology can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
About 73.0% of the company shares are owned by institutional investors
Latest headline from finance.yahoo.com: Exelixis Q4 Earnings and Revenues Beat Estimates

Puma Biotechnology Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Puma Stock often depends not only on the future outlook of the current and potential Puma Biotechnology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Puma Biotechnology's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding49.1 M
Cash And Short Term Investments101 M

Puma Biotechnology Fundamentals Growth

Puma Stock prices reflect investors' perceptions of the future prospects and financial health of Puma Biotechnology, and Puma Biotechnology fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Puma Stock performance.

About Puma Biotechnology Performance

By evaluating Puma Biotechnology's fundamental ratios, stakeholders can gain valuable insights into Puma Biotechnology's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Puma Biotechnology has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Puma Biotechnology has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 56.86  52.91 
Return On Tangible Assets 0.17  0.18 
Return On Capital Employed 0.24  0.25 
Return On Assets 0.14  0.13 
Return On Equity 0.30  0.31 

Things to note about Puma Biotechnology performance evaluation

Checking the ongoing alerts about Puma Biotechnology for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Puma Biotechnology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
About 73.0% of the company shares are owned by institutional investors
Latest headline from finance.yahoo.com: Exelixis Q4 Earnings and Revenues Beat Estimates
Evaluating Puma Biotechnology's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Puma Biotechnology's stock performance include:
  • Analyzing Puma Biotechnology's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Puma Biotechnology's stock is overvalued or undervalued compared to its peers.
  • Examining Puma Biotechnology's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Puma Biotechnology's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Puma Biotechnology's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Puma Biotechnology's stock. These opinions can provide insight into Puma Biotechnology's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Puma Biotechnology's stock performance is not an exact science, and many factors can impact Puma Biotechnology's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Puma Stock analysis

When running Puma Biotechnology's price analysis, check to measure Puma Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Puma Biotechnology is operating at the current time. Most of Puma Biotechnology's value examination focuses on studying past and present price action to predict the probability of Puma Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Puma Biotechnology's price. Additionally, you may evaluate how the addition of Puma Biotechnology to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes